Development and External Validation of a Highly Accurate Nomogram for the Prediction of Perioperative Mortality After Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Journal of Urology

Volumn 182, Issue 2, 2009, Pages 626-632

  Jeldres, Claudio ^a,b   Isbarn, Hendrik ^a,e   Capitanio, Umberto ^a,c   Zini, Laurent ^d   Bhojani, Naeem ^a,b   Shariat, Shahrokh F ^a   Cloutier, Vincent ^b   Lattouf, Jean Baptiste ^b   Duclos, Alain ^b   Jolivet Tremblay, Martine ^b   Valiquette, Luc ^b   Saad, Fred ^b   Graefen, Markus ^e   Montorsi, Francesco ^c   Perrotte, Paul ^b   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

mortality; prostatic hyperplasia; transurethral resection of prostate

Indexed keywords

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE HYPERTROPHY; RISK FACTOR; SURGICAL MORTALITY; TRANSURETHRAL RESECTION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 67649804611     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.04.008     Document Type: Article

References (30)

1. Arrighi H.M., Metter E.J., Guess H.A., et al. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 38 (1991) 4
2. Wasson J.H., Reda D.J., Bruskewitz R.C., et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 332 (1995) 75
3. McConnell J.D., Bruskewitz R., Walsh P., et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 338 (1998) 557
4. Reich O., Gratzke C., and Stief C.G. Techniques and long-term results of surgical procedures for BPH. Eur Urol 49 (2006) 970
5. Yu X., Elliott S.P., Wilt T.J., et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 180 (2008) 241
6. Wei J.T., Calhoun E., and Jacobsen S.J. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol 173 (2005) 1256
7. Concato J., Horwitz R.I., Feinstein A.R., et al. Problems of comorbidity in mortality after prostatectomy. JAMA 267 (1992) 1077
8. Hahn R.G., Farahmand B.Y., Hallin A., et al. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 55 (2000) 236
9. Holman C.D., Wisniewski Z.S., Semmens J.B., et al. Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia. BJU Int 84 (1999) 37
10. Thorpe A.C., Cleary R., Coles J., et al. Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group. Br J Urol 74 (1994) 559
11. Lu-Yao G.L., Barry M.J., Chang C.H., et al. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). Urology 44 (1994) 692
12. Chen Y.K., and Lin H.C. Association between urologists' caseload volume and in-hospital mortality for transurethral resection of prostate: a nationwide population-based study. Urology 72 (2008) 329
13. Wasson J.H., Bubolz T.A., Lu-Yao G.L., et al. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol 164 (2000) 1212
14. Nielsen S.S., Thulstrup A.M., Lund L., et al. Postoperative mortality in patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish nationwide cohort study. BJU Int 87 (2001) 183
15. Koshiba K., Egawa S., Ohori M., et al. Does transurethral resection of the prostate pose a risk to life?. 22-Year outcome. J Urol 153 (1995) 1506
16. Reich O., Gratzke C., Bachmann A., et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180 (2008) 246
17. Seagroatt V. Mortality after prostatectomy: selection and surgical approach. Lancet 346 (1995) 1521
18. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373
19. Walz J., Montorsi F., Jeldres C., et al. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases. BJU Int 101 (2008) 826
20. Walz J., Gallina A., Perrotte P., et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 100 (2007) 1254
21. Walz J., Gallina A., Saad F., et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 25 (2007) 3576
22. Walz J., Suardi N., Shariat S.F., et al. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU Int 102 (2008) 33
23. Jeldres C., Suardi N., Saad F., et al. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol 54 (2008) 97
24. Jeldres C., Suardi N., Walz J., et al. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. Eur Urol 54 (2008) 107
25. Hens N., Aerts M., and Molenberghs G. Model selection for incomplete and design-based samples. Stat Med 25 (2006) 2502
26. Laberge A.M., Michaud J., Richter A., et al. Population history and its impact on medical genetics in Quebec. Clin Genet 68 (2005) 287
27. Mhatre S.L., and Deber R.B. From equal access to health care to equitable access to health: a review of Canadian provincial health commissions and reports. Int J Health Serv 22 (1992) 645
28. Nickel J.C., Herschorn S., Corcos J., et al. Canadian guidelines for the management of benign prostatic hyperplasia. Can J Urol 12 (2005) 2677
29. de laRosette J.J., Alivizatos G., Madersbacher S., et al. EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 40 (2001) 256
30. Hahn R.G., and Ekengren J.C. Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol 149 (1993) 502